Cargando…
Selection of Nanobodies that Target Human Neonatal Fc Receptor
FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552320/ https://www.ncbi.nlm.nih.gov/pubmed/23346375 http://dx.doi.org/10.1038/srep01118 |
_version_ | 1782256662765109248 |
---|---|
author | Andersen, Jan Terje Gonzalez-Pajuelo, Maria Foss, Stian Landsverk, Ole J. B. Pinto, Débora Szyroki, Alexander de Haard, Hans J. Saunders, Michael Vanlandschoot, Peter Sandlie, Inger |
author_facet | Andersen, Jan Terje Gonzalez-Pajuelo, Maria Foss, Stian Landsverk, Ole J. B. Pinto, Débora Szyroki, Alexander de Haard, Hans J. Saunders, Michael Vanlandschoot, Peter Sandlie, Inger |
author_sort | Andersen, Jan Terje |
collection | PubMed |
description | FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus, there is an intense interest in studies of how FcRn binds and transports its cargo within and across several types of cells, and FcRn detection reagents are in high demand. Here we report on phage display-selected Nanobodies that target human FcRn. The Nanobodies were obtained from a variable-domain repertoire library isolated from a llama immunized with recombinant human FcRn. One candidate, Nb218-H4, was shown to bind FcRn with high affinity at both acidic and neutral pH, without competing ligand binding and interfering with FcRn functions, such as transcytosis of IgG. Thus, Nb218-H4 can be used as a detection probe and as a tracker for visualization of FcRn-mediated cellular transport. |
format | Online Article Text |
id | pubmed-3552320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-35523202013-01-23 Selection of Nanobodies that Target Human Neonatal Fc Receptor Andersen, Jan Terje Gonzalez-Pajuelo, Maria Foss, Stian Landsverk, Ole J. B. Pinto, Débora Szyroki, Alexander de Haard, Hans J. Saunders, Michael Vanlandschoot, Peter Sandlie, Inger Sci Rep Article FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus, there is an intense interest in studies of how FcRn binds and transports its cargo within and across several types of cells, and FcRn detection reagents are in high demand. Here we report on phage display-selected Nanobodies that target human FcRn. The Nanobodies were obtained from a variable-domain repertoire library isolated from a llama immunized with recombinant human FcRn. One candidate, Nb218-H4, was shown to bind FcRn with high affinity at both acidic and neutral pH, without competing ligand binding and interfering with FcRn functions, such as transcytosis of IgG. Thus, Nb218-H4 can be used as a detection probe and as a tracker for visualization of FcRn-mediated cellular transport. Nature Publishing Group 2013-01-23 /pmc/articles/PMC3552320/ /pubmed/23346375 http://dx.doi.org/10.1038/srep01118 Text en Copyright © 2013, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Article Andersen, Jan Terje Gonzalez-Pajuelo, Maria Foss, Stian Landsverk, Ole J. B. Pinto, Débora Szyroki, Alexander de Haard, Hans J. Saunders, Michael Vanlandschoot, Peter Sandlie, Inger Selection of Nanobodies that Target Human Neonatal Fc Receptor |
title | Selection of Nanobodies that Target Human Neonatal Fc Receptor |
title_full | Selection of Nanobodies that Target Human Neonatal Fc Receptor |
title_fullStr | Selection of Nanobodies that Target Human Neonatal Fc Receptor |
title_full_unstemmed | Selection of Nanobodies that Target Human Neonatal Fc Receptor |
title_short | Selection of Nanobodies that Target Human Neonatal Fc Receptor |
title_sort | selection of nanobodies that target human neonatal fc receptor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552320/ https://www.ncbi.nlm.nih.gov/pubmed/23346375 http://dx.doi.org/10.1038/srep01118 |
work_keys_str_mv | AT andersenjanterje selectionofnanobodiesthattargethumanneonatalfcreceptor AT gonzalezpajuelomaria selectionofnanobodiesthattargethumanneonatalfcreceptor AT fossstian selectionofnanobodiesthattargethumanneonatalfcreceptor AT landsverkolejb selectionofnanobodiesthattargethumanneonatalfcreceptor AT pintodebora selectionofnanobodiesthattargethumanneonatalfcreceptor AT szyrokialexander selectionofnanobodiesthattargethumanneonatalfcreceptor AT dehaardhansj selectionofnanobodiesthattargethumanneonatalfcreceptor AT saundersmichael selectionofnanobodiesthattargethumanneonatalfcreceptor AT vanlandschootpeter selectionofnanobodiesthattargethumanneonatalfcreceptor AT sandlieinger selectionofnanobodiesthattargethumanneonatalfcreceptor |